Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Rutkowski

Showing results (261-270 of 491) with videos related to

Pageof 50
Sort By:
The Lancet. Oncology|February 26, 2018
Adjuvant vemurafenib in resected, BRAF<sup>V600</sup> mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichele Maio, Karl Lewis, Lev Demidov, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2015
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinibChee Khoon Lee, David Goldstein, Emma Gibbs, et al.
Cancers|July 2, 2021
Efficacy and Safety of Hypofractionated Preoperative Radiotherapy for Primary Locally Advanced Soft Tissue Sarcomas of Limbs or Trunk WallHanna Koseła-Paterczyk, Paweł Teterycz, Mateusz J Spałek, et al.
Medical Oncology (Northwood, London, England)|July 11, 2014
Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applicationsJoanna Przybyl, Katarzyna Kozak, Hanna Kosela, et al.
Annals of Surgical Oncology|June 3, 2015
Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bonePiotr Rutkowski, Stefano Ferrari, Robert J Grimer, et al.
Cancers|October 29, 2020
Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern ImmunotherapyPawel Teterycz, Anna M Czarnecka, Alice Indini, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 7, 2021
Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter studySylvie Bonvalot, Jay Wunder, Alessandro Gronchi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2025
Real-life data on tebentafusp in metastatic uveal melanoma patients from four EURACAN Expert CentresMonique K van der Kooij, Ellen Kapiteijn, Piotr Rutkowski, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2018
The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'Patrick Schöffski, Agnieszka Wozniak, Michael G Leahy, et al.
Contemporary Oncology (Poznan, Poland)|July 7, 2025
Chemotherapy efficacy in advanced melanoma patients after failure of immune checkpoint and BRAF/MEK inhibitorsŁukasz Galus, Daria Tusień Małecka, Michał Michalak, et al.
Pageof 50

Showing results (261-270 of 491) with videos related to

Sort By:
Pageof 50
The Lancet. Oncology|February 26, 2018
Adjuvant vemurafenib in resected, BRAF<sup>V600</sup> mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichele Maio, Karl Lewis, Lev Demidov, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2015
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinibChee Khoon Lee, David Goldstein, Emma Gibbs, et al.
Cancers|July 2, 2021
Efficacy and Safety of Hypofractionated Preoperative Radiotherapy for Primary Locally Advanced Soft Tissue Sarcomas of Limbs or Trunk WallHanna Koseła-Paterczyk, Paweł Teterycz, Mateusz J Spałek, et al.
Medical Oncology (Northwood, London, England)|July 11, 2014
Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applicationsJoanna Przybyl, Katarzyna Kozak, Hanna Kosela, et al.
Annals of Surgical Oncology|June 3, 2015
Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bonePiotr Rutkowski, Stefano Ferrari, Robert J Grimer, et al.
Cancers|October 29, 2020
Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern ImmunotherapyPawel Teterycz, Anna M Czarnecka, Alice Indini, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 7, 2021
Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter studySylvie Bonvalot, Jay Wunder, Alessandro Gronchi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2025
Real-life data on tebentafusp in metastatic uveal melanoma patients from four EURACAN Expert CentresMonique K van der Kooij, Ellen Kapiteijn, Piotr Rutkowski, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2018
The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'Patrick Schöffski, Agnieszka Wozniak, Michael G Leahy, et al.
Contemporary Oncology (Poznan, Poland)|July 7, 2025
Chemotherapy efficacy in advanced melanoma patients after failure of immune checkpoint and BRAF/MEK inhibitorsŁukasz Galus, Daria Tusień Małecka, Michał Michalak, et al.
Pageof 50